Table 2.
Questionnaire items before and after treatment with placebo and Arthrocen.
| Item | Group † | Before Treatment (±S.E.M) | After Treatment (±S.E.M) | p-Value ‡ |
|---|---|---|---|---|
| SF-20 | Placebo | 46.09 ± 15.8 | 48.69 ± 14.8 | p = 0.116 |
| Arthrocen | 45.41 ± 15.9 | 52.29 ± 14.9 | p < 0.001 | |
| p-value | p = 0.147 | p = 0.295 | - | |
| WOMAC | Placebo | 63.98 ± 16- 1 | 55.85 ± 18.9 | p < 0.79 |
| Arthrocen | 67.56 ± 15.3 | 56.59 ± 17.8 | p < 0.001 | |
| p-value | p = 0.312 | p = 0.83 | - | |
| LISOK | Placebo | 21.06 ± 0.6 | 20.4 ± 0.6 | p < 0.29 |
| Arthrocen | 21.1 ± 0.6 | 20.9 ± 0.6 | p = 0.69 | |
| p-value | p = 0.9 | p = 0.5 | - | |
| VAS (pain) | Placebo | 4.6 ± 0.3 | 3.76 ± 0.3 | p < 0.01 |
| Arthrocen | 4.4 ± 0.3 | 3.56 ± 0.2 | p < 0.001 | |
| p-value | p = 0.67 | p = 0.66 | - |
† p-value in this column represents the pre-test and post-test differences between placebo and Arthrocen groups. ‡ p-value in this column represents the difference in pre-test and post-test values within placebo and Arthrocen groups.